Ultragenyx Pharmaceutical | RARE - Custo de Mercadoria Vendida





Custo de Mercadoria Vendida Alterar Data
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Insmed USD 49.5M 3.34M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Kyowa Hakko Kirin JPY 33B 4.87B 2026-03
MacroGenics USD 9.53M 585K 2026-03
Moderna USD 955M 503M 2026-03
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 392.8M 73.2M 2026-03
Xoma 116K 112.7K 2024-06